Generics bulletin-i provides intelligence on the move for the generic medicines industry. Its subscribers benefit from the latest commercial intelligence about business opportunities in the worldwide generic medicines and biosimilars markets.
They also get access to more than five years of back issues in a fully-searchable archive. This offers an invaluable resource for researching market opportunities, benchmarking competitive strengths, evaluating regulatory changes and assessing product developments.
Senior executives in the worlds leading global, regional and national generic medicines companies – as well as a broad spectrum of industry watchers and suppliers – make sure they regularly read Generics bulletin, the world’s leading newsletter for the generic medicines industry.
Published 20-times a year – twice-monthly in most months – its accurate and reliable reports provide insights into the strategies of significant generics and biosimilar companies and analyse their business performance, plans and product portfolios.
Patent and pricing issues, legal rulings, regulatory changes, government initiatives, market opportunities, and industry consolidation provide the wider context for Generics bulletins comprehensive global coverage.
Subscription options
1 month at £94.99.
The subscription will include the current issue if you do not already own it and subsequently published future issues. Payment will be charged to your app store account at confirmation of purchase. This subscription will automatically renew unless auto-renew is turned off at least 24-hours before the end of the current period, your account will be charged for renewal within 24-hours prior to the end of the current period. The cost of the renewal will match the initial subscription price.
You may turn off auto-renewing subscriptions by going to your user’s Account Settings after purchase. No cancellation of the current subscription is allowed during your active subscription period.